DHS 75.24(19)(d)(d) A service may offer medication management for treatment of substance use disorders or mental health disorders. A service shall have written policies and procedures for medication management services, including: DHS 75.24(19)(d)2.2. Prescriber checks and use of the Wisconsin Prescription Drug Monitoring Program database. DHS 75.24(19)(d)3.3. Procedures for obtaining and updating patient consents for medications received. DHS 75.24(19)(d)4.4. Procedures for reporting and reviewing medication errors via facility incident reports or other documentation. DHS 75.24(19)(e)(e) When a patient’s treatment includes medication management, it shall be documented as a goal in the patient’s treatment plan. The treatment plan shall be signed by the prescriber. DHS 75.24(19)(f)(f) If a patient is prescribed medication as part of the treatment plan, the service shall obtain a separate consent that indicates that the prescriber has explained to the patient, or the patient’s legal representative, if applicable, the nature, risks and benefits of the medication and that the patient, or legal representative, understands the explanation and consents to the use of the medication. DHS 75.24(19)(g)(g) A service shall maintain medication records that allow for ongoing monitoring of any medication prescribed or administered by the service, and documentation of any adverse drug reactions or medication errors. Medication orders shall specify the name of the medication, dose, route of administration, frequency of administration, name of the prescriber who prescribed the medication, prescriber signature, and staff administering the medication, if applicable. DHS 75.24(19)(h)(h) A service that receives, stores, or dispenses medications shall have written policies and procedures regarding storage, dispensing, and disposal of medications, including: DHS 75.24(19)(h)1.1. Patient name, medication name, amount of medication, dosage, date of receipt, and date of dispensing or disposal. DHS 75.24(19)(i)(i) A non-residential service that receives, stores, or dispenses medications shall comply with 21 CFR 1301.72. The medication storage area shall be clean, and shall be separated by a wall from any restroom, cleaning products, or any food-preparation or storage area. DHS 75.24(20)(a)(a) A service shall have written policies and procedures for drug testing, breath analysis, and toxicology services. Patients of a service shall be informed of these policies and procedures upon admission. DHS 75.24(20)(b)(b) A service may utilize drug testing information in conjunction with patient self-report, behavioral observations, collateral information, and clinical assessment to make determinations regarding patient care. DHS 75.24(20)(c)(c) A service shall have a method for obtaining confirmation of drug testing results. DHS 75.24(20)(d)(d) A service shall inform patients of the costs for drug testing services. DHS 75.24(20)(e)(e) A service shall obtain informed consent before releasing patient drug testing results. The service is responsible for ensuring that the patient understands possible consequences of disclosure of drug testing information. DHS 75.24(21)(21) Transfer. If the service transfers a patient to another provider or if a change is made in the patient’s level of care, the transfer or change in the level of care shall be documented in the patient’s case record. A transfer summary shall be entered into the patient’s case record, including the following: DHS 75.24(21)(b)(b) A completed copy of the standardized placement criteria and level of care recommended. DHS 75.24(21)(c)(c) Documentation of communication and follow-up that ensures continuity of care from one provider or level of care to another. DHS 75.24(22)(a)(a) A patient may be discharged from a service for any of the following reasons: DHS 75.24(22)(a)1.1. Successful completion of recommended services and treatment plan goals. DHS 75.24(22)(a)2.2. No longer meeting placement criteria for any level of care in the substance use treatment system.